SCHEMBL14010644

SCHEMBL14010644

Cc1ccc(N(c2ccc(-c3ccc(N(c4ccc(C)cc4)c4ccc5c6c(cccc46)-c4ccccc4-5)cc3)cc2)c2ccc3c4c(cccc24)-c2ccccc2-3)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
MAPT P10636 3/20 0.40
PABPC1 P11940 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CRHBP P24387 2/20 0.39
CRHR2 Q13324 2/20 0.39
KEAP1 Q14145 2/20 0.39
NFE2L2 Q16236 2/20 0.39
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
POLB P06746 1/20 0.37
USP2 O75604 3/20 0.37
CRHR1 P34998 1/20 0.36
ALDH1A1 P00352 5/20 0.35
HPGD P15428 3/20 0.35
GAA P10253 2/20 0.35
LMNA P02545 1/20 0.35
CASP1 P29466 3/20 0.34
HSD17B10 Q99714 3/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10072075 0.95 KDM4E (0.42) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL10128557 0.92 KDM4E (0.41) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL23546630 0.89 CRHBP (0.42) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL5002787 0.89 CRHBP (0.42) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL14491574 0.89 CRHBP (0.42) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL14010647 0.89 CRHBP (0.44) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL14010643 0.89 MEN1 (0.37) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL13358340 0.89 APP (0.39) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL23546674 0.88 CRHBP (0.41) KDM4EMAPTPABPC1SMN1; SMN2CRHBP
SCHEMBL12566482 0.88 CRHBP (0.41) KDM4EMAPTPABPC1SMN1; SMN2CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080278065-A1 Organic Electroluminescent Element and Display Apparatus SONY CORPORATION (JP) 2008-11-13 US disclosed
US-20080278065-A1 Organic Electroluminescent Element and Display Apparatus SONY CORPORATION (JP) 2008-11-13 US disclosed
US-20070149815-A1 Organic light-emitting material and method for producing an organic material SONY CORPORATION (JP) 2007-06-28 US disclosed
US-20070149815-A1 Organic light-emitting material and method for producing an organic material SONY CORPORATION (JP) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149815-A1 Organic light-emitting material and method for producing an organic material CRY1, CRY2, IK KDM4E 2873/4885MAPT 1013/4885PABPC1 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.